Autolus Therapeutics Cash Flow Statement (2017-2026) | AUTL

Cash Flow Statement Dec2017 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income (Quarter)
-33.17M-33.99M-41.71M-37.06M-42.06M-42.77M-26.98M-39.81M-45.55M-45.85M-77.17M-52.69M-58.27M-82.09M-27.61M-70.16M-47.92M-79.12M-90.36M-39.11M
Depreciation and Depletion (Quarter)
2.20M2.40M2.10M2.00M1.90M1.80M1.60M1.90M1.50M1.40M1.80M1.80M1.90M1.90M2.00M2.00M2.10M2.10M2.10M2.20M
Share-based Compensation (Quarter)
1.28M27.91M-18.58M2.34M2.92M3.34M3.42M5.17M27.73M8.31M-0.06M2.28M2.94M4.02M6.23M2.87M4.29M3.83M3.44M
Deferred Taxes (Quarter)
-0.40M-0.23M0.42M0.17M0.25M0.16M-0.32M0.20M0.09M0.24M0.47M0.23M-0.07M0.17M-0.14M-0.49M-0.38M-0.01M1.17M
Asset Writedowns and Impairment (Quarter)
0.38M0.02M0.41M2.50M4.30M4.70M1.20M
Cash from Operations (Quarter)
-36.61M-34.75M-9.16M-35.03M-30.81M-31.90M-14.57M-42.42M-38.15M-40.19M-24.83M-40.51M-51.08M-76.74M-37.93M-75.56M-72.78M-67.90M-67.32M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
1.19M0.82M
Depreciation & Amortization (CF) (Quarter)
2.24M2.45M2.10M2.07M1.92M1.79M1.65M1.90M1.51M1.38M1.77M1.81M1.90M1.94M1.92M1.99M2.08M2.08M2.14M2.20M
Change in Working Capital
Change in Receivables (Quarter)
14.34M12.39M6.00M-8.57M
Change in Inventory (Quarter)
4.23M10.10M11.44M8.60M10.11M
Change in Account Payables (Quarter)
-2.37M0.50M-1.03M-0.27M-0.05M0.23M0.11M-0.23M3.49M-3.19M-0.58M1.32M-0.34M0.28M0.33M1.86M1.53M5.42M-7.52M
Other Working Capital Changes (Quarter)
-0.09M-0.10M-0.15M-0.18M-0.07M-0.05M0.14M-1.80M-0.02M-0.12M0.21M-0.08M-0.08M-0.13M-0.65M4.72M-0.02M2.91M-7.35M
Investing Activities
Capital Expenditures (Quarter)
1.51M3.86M1.58M0.77M4.14M5.29M0.63M3.69M4.32M1.50M1.48M0.56M0.82M9.59M11.11M8.24M7.28M4.41M-0.89M
Change in Acquisitions & Divestments (Quarter)
20.00M151.19M130.98M126.04M
Cash from Investing Activities (Quarter)
-1.51M-3.86M-1.58M-0.77M-2.64M-6.80M-0.63M-3.62M-4.39M-1.50M-1.48M-0.53M-0.84M-9.59M-383.59M-59.55M95.92M35.55M86.54M
Financing Activities
Other financing activities (Quarter)
0.13M-0.00M0.12M0.00M0.02M0.28M0.12M0.18M0.01M
Cash from Financing Activities (Quarter)
13.55M-0.23M147.41M-0.00M0.10M223.51M-0.69M-0.22M0.00M0.02M561.44M-2.08M0.18M30.01M-0.77M-1.77M-1.80M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
5.98M-0.36M109.38M163.85M549.98M
Additional items
Exchange Rate Effect (Quarter)
1.33M-4.45M0.73M-5.98M-18.68M-14.79M11.08M7.33M7.23M-9.30M9.77M-1.19M1.42M37.72M-38.22M3.56M5.71M-3.58M0.59M
Change in Cash (Quarter)
-23.24M-43.29M137.41M-41.78M-52.13M-53.39M219.39M-39.41M-35.52M-50.98M-16.51M519.21M-52.59M-48.42M-429.73M-131.55M28.08M-37.71M18.01M
Free Cash Flow (Quarter)
-38.12M-38.61M-10.74M-35.80M-34.95M-37.20M-15.20M-46.11M-42.47M-41.69M-26.31M-41.07M-51.90M-86.33M-49.05M-83.81M-80.06M-72.31M-66.44M
Net Cash Flow (Quarter)
-24.57M-38.84M136.67M-35.80M-33.45M-38.60M208.31M-46.73M-42.76M-41.68M-26.29M520.39M-54.00M-86.14M-391.52M-135.11M22.37M-34.13M17.42M